v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 45,100 $ (19,915)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 44,731 50,672
Amortization of debt issuance costs 2,198 3,219
Provision for credit losses 1,995 1,542
Stock-based compensation expense 26,634 4,022
Non-cash lease expense 2,489 2,459
Deferred income tax 13,022 (6,007)
Loss on debt extinguishment 7,366 0
Contingent consideration revaluation 12,629 5,100
Post-conversion earnout share liability revaluation (2,675) 0
Change in operating assets and liabilities:    
Accounts receivable (12,780) (63,806)
Income tax receivable 618 132
Prepaid expenses and other current assets 3,522 (11,205)
Other assets (2,889) (1,501)
Accounts payable (8,006) 79,681
Accrued liabilities 20,488 28,401
Other current liabilities 1,430 1,173
Other long-term liabilities (4,395) 3,930
Net cash provided by operating activities 151,477 77,897
Cash flows from investing activities:    
Purchase and capitalization of property, equipment and software (27,247) (24,901)
Net cash used in investing activities (27,247) (24,901)
Cash flows from financing activities:    
Proceeds from the exercise of stock options 2,255 1,237
Proceeds from issuance of preferred stock 0 409,545
Proceeds from post-conversion earnout share liability 0 5,393
Proceeds from initial public offering, net of underwriting discounts and commissions 472,397 0
Repurchase of common stock 0 (383,389)
Payment of debt principal (418,438) (7,563)
Payment of deferred offering costs (8,359) 0
Net cash provided by financing activities 47,855 25,223
Effect of exchange rate on cash, cash equivalents, and restricted cash 7 663
Net increase in cash, cash equivalents, and restricted cash 172,092 78,882
Cash, cash equivalents, and restricted cash, beginning of period 134,095 99,088
Cash, cash equivalents, and restricted cash, end of period 306,187 177,970
Components of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 305,398 177,181
Restricted cash 789 789
Total cash, cash equivalents, and restricted cash 306,187 177,970
Supplemental disclosures of cash flow information:    
Cash paid for income taxes, net of income tax refunds received 8,324 5,882
Cash paid for interest 71,006 65,318
Cash paid for amounts included in the measurement of operating lease liabilities 3,088 2,389
Supplemental disclosures of noncash investing and financing activities:    
Conversion of Series A Redeemable Convertible Preferred Stock to common stock upon initial public offering 414,607 0
Right-of-use assets obtained in exchange for operating lease liabilities, net of modifications 568 8,341
Amounts related to issuance of preferred stock and repurchase of common stock and vested stock-based compensation awards, received and paid through escrow 0 5,062
Unpaid deferred offering costs 7,969 0
Unpaid property and equipment included in accounts payable 47 459
Unpaid repurchase of vested options and SARs $ 0 $ 20,897